AGP Picks
View all

Age-related macular degeneration market to reach $15.42 billion by 2030

Oct. 30, 2026
Age-related macular degeneration market to reach $15.42 billion by 2030
By AI, Created 17:15 UTC, Oct 30, 2026, AGP -

The global age-related macular degeneration market is projected to grow from $11.46 billion in 2026 to $15.42 billion by 2030, driven by an aging population, rising case counts and broader treatment access. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - The age-related macular degeneration market is expanding as more people need treatment for a leading cause of central vision loss. - The market outlook reflects rising demand for therapies, stronger eye-care infrastructure and faster adoption of newer treatment approaches. - The Business Research Company’s forecast points to a larger commercial opportunity for drugmakers, clinics and pharmacy channels serving eye disease patients.

What happened: - The Business Research Company published its Age-Related Macular Degeneration Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report estimates the market will rise from $10.67 billion in 2025 to $11.46 billion in 2026. - The report projects the market will reach $15.42 billion by 2030. - The report puts the 2025-2026 growth rate at 7.5% and the 2026-2030 growth rate at 7.7%. - A free sample of the report is available here.

The details: - Age-related macular degeneration is a progressive disorder that affects the macula, the central part of the retina responsible for sharp central vision. - As the macula deteriorates with age, patients can lose central vision over time. - Common management approaches include regular eye check-ups, healthier lifestyle habits and nutritional supplements designed to slow disease progression. - The report links recent growth to the global aging population, increasing AMD cases, limited early treatment options in the past, rising awareness of eye health and expansion of hospital and ophthalmology clinic infrastructure worldwide. - The report expects future growth to come from advanced anti-VEGF drugs, higher investment in ophthalmology research, growth of specialty and online pharmacy channels, more combination therapies and more personalized treatment methods. - The report says North America held the largest share of the global market in 2025. - The report says Asia-Pacific is expected to grow fastest during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A full report is available here.

Between the lines: - The forecast suggests AMD treatment is shifting from basic care toward more specialized and longer-term management. - Rising prevalence is the clearest demand signal, and it gives the market a patient-driven growth base rather than a purely technology-driven one. - The emphasis on specialty pharmacies, online channels and personalized treatment points to a more distributed and more tailored care model.

What's next: - The report’s forecast period points to continued market expansion through 2030 as treatment access and product innovation improve. - Greater investment in ophthalmology research and broader use of advanced therapies could reshape how AMD is diagnosed and managed. - Regional growth is likely to remain uneven, with mature markets leading in current size and emerging markets contributing more to future growth. - The company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Lifestyle Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Lifestyle Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.